MB and acute coronary syndrome: Several studies have shown that the use of MCB tests—such as troponin I, CK-MB, and myoglobin, which are related to cardiomyocyte necrosis, or BNP, which is related to cardiomyocyte function—can effectively improve the risk classification of patients with acute coronary syndrome.